Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116012552> ?p ?o ?g. }
- W2116012552 endingPage "11" @default.
- W2116012552 startingPage "6" @default.
- W2116012552 abstract "Maintenance treatment for patients with acute myeloid leukemia (AML) in remission has recently been controversially discussed and even abandoned by several groups. An analysis of 16 published multicenter trials, however, revealed the highest probabilities of relapse free survival (RFS) in the range of 35-42 % at 4-5 years only in patients assigned to maintenance treatment when adult age and intent-to-treat conditions were considered. After having demonstrated a superior RFS from 3 year maintenance following standard dose consolidation over that from consolidation alone (p<0.0001), the German AMLCG requestioned the effect of maintenance randomly compared with sequential high-dose AraC and Mitoxantrone (S-HAM) in patients having received intensified induction treatment. The RFS shows an advantage for maintenance with 32 % versus 25 % (p= .021). We conclude that maintenance treatment continues to substantially contribute to the management of adult patients with AML, even as part of recent strategies using intensified induction treatment, and thus appears necessary in these settings." @default.
- W2116012552 created "2016-06-24" @default.
- W2116012552 creator A5004330294 @default.
- W2116012552 creator A5008433641 @default.
- W2116012552 creator A5012908062 @default.
- W2116012552 creator A5014917310 @default.
- W2116012552 creator A5019876747 @default.
- W2116012552 creator A5025105470 @default.
- W2116012552 creator A5025613660 @default.
- W2116012552 creator A5025663121 @default.
- W2116012552 creator A5031462285 @default.
- W2116012552 creator A5033935778 @default.
- W2116012552 creator A5037964831 @default.
- W2116012552 creator A5038047169 @default.
- W2116012552 creator A5039428434 @default.
- W2116012552 creator A5042946623 @default.
- W2116012552 creator A5043414993 @default.
- W2116012552 creator A5043530605 @default.
- W2116012552 creator A5054794845 @default.
- W2116012552 creator A5055749359 @default.
- W2116012552 creator A5057268503 @default.
- W2116012552 creator A5060989356 @default.
- W2116012552 creator A5063547268 @default.
- W2116012552 creator A5071091625 @default.
- W2116012552 creator A5071341802 @default.
- W2116012552 creator A5078376583 @default.
- W2116012552 creator A5079368509 @default.
- W2116012552 creator A5090793417 @default.
- W2116012552 creator A5091046135 @default.
- W2116012552 creator A5091537377 @default.
- W2116012552 date "2004-01-01" @default.
- W2116012552 modified "2023-09-26" @default.
- W2116012552 title "Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo- therapy" @default.
- W2116012552 cites W1143126211 @default.
- W2116012552 cites W118967028 @default.
- W2116012552 cites W144898347 @default.
- W2116012552 cites W1492445977 @default.
- W2116012552 cites W1493398929 @default.
- W2116012552 cites W1519562949 @default.
- W2116012552 cites W1585733692 @default.
- W2116012552 cites W1591796471 @default.
- W2116012552 cites W1694878186 @default.
- W2116012552 cites W1963335440 @default.
- W2116012552 cites W1995439059 @default.
- W2116012552 cites W2006691924 @default.
- W2116012552 cites W2013051826 @default.
- W2116012552 cites W2027967630 @default.
- W2116012552 cites W2033902902 @default.
- W2116012552 cites W207118996 @default.
- W2116012552 cites W2081532971 @default.
- W2116012552 cites W2083600033 @default.
- W2116012552 cites W2098854099 @default.
- W2116012552 cites W2167571044 @default.
- W2116012552 cites W2167578566 @default.
- W2116012552 cites W2203305889 @default.
- W2116012552 cites W2252759819 @default.
- W2116012552 cites W2315152253 @default.
- W2116012552 cites W2318674152 @default.
- W2116012552 cites W49953563 @default.
- W2116012552 hasPublicationYear "2004" @default.
- W2116012552 type Work @default.
- W2116012552 sameAs 2116012552 @default.
- W2116012552 citedByCount "0" @default.
- W2116012552 crossrefType "journal-article" @default.
- W2116012552 hasAuthorship W2116012552A5004330294 @default.
- W2116012552 hasAuthorship W2116012552A5008433641 @default.
- W2116012552 hasAuthorship W2116012552A5012908062 @default.
- W2116012552 hasAuthorship W2116012552A5014917310 @default.
- W2116012552 hasAuthorship W2116012552A5019876747 @default.
- W2116012552 hasAuthorship W2116012552A5025105470 @default.
- W2116012552 hasAuthorship W2116012552A5025613660 @default.
- W2116012552 hasAuthorship W2116012552A5025663121 @default.
- W2116012552 hasAuthorship W2116012552A5031462285 @default.
- W2116012552 hasAuthorship W2116012552A5033935778 @default.
- W2116012552 hasAuthorship W2116012552A5037964831 @default.
- W2116012552 hasAuthorship W2116012552A5038047169 @default.
- W2116012552 hasAuthorship W2116012552A5039428434 @default.
- W2116012552 hasAuthorship W2116012552A5042946623 @default.
- W2116012552 hasAuthorship W2116012552A5043414993 @default.
- W2116012552 hasAuthorship W2116012552A5043530605 @default.
- W2116012552 hasAuthorship W2116012552A5054794845 @default.
- W2116012552 hasAuthorship W2116012552A5055749359 @default.
- W2116012552 hasAuthorship W2116012552A5057268503 @default.
- W2116012552 hasAuthorship W2116012552A5060989356 @default.
- W2116012552 hasAuthorship W2116012552A5063547268 @default.
- W2116012552 hasAuthorship W2116012552A5071091625 @default.
- W2116012552 hasAuthorship W2116012552A5071341802 @default.
- W2116012552 hasAuthorship W2116012552A5078376583 @default.
- W2116012552 hasAuthorship W2116012552A5079368509 @default.
- W2116012552 hasAuthorship W2116012552A5090793417 @default.
- W2116012552 hasAuthorship W2116012552A5091046135 @default.
- W2116012552 hasAuthorship W2116012552A5091537377 @default.
- W2116012552 hasConcept C126322002 @default.
- W2116012552 hasConcept C143998085 @default.
- W2116012552 hasConcept C177713679 @default.
- W2116012552 hasConcept C2776694085 @default.
- W2116012552 hasConcept C2778283404 @default.
- W2116012552 hasConcept C2778461978 @default.